Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Emissions of 2,3,7,8-substituted and non-2,3,7,8-substituted polychlorinated dibenzo-p-dioxins and dibenzofurans from secondary aluminum smelters.

Haifeng Li | Wenbin Liu | Chen Tang | Rongrong Lei | Xiaolin Wu | Lirong Gao | Guijin Su
Chemosphere | 2019

The secondary aluminum smelting industry is an important source of polychlorinated dibenzo-p-dioxin and dibenzofurans (PCDD/Fs). However, the formations and emissions of non-2,3,7,8-PCDD/Fs have rarely been studied. Non-2,3,7,8-PCDD/Fs may also be metabolically toxic to mammalians. In this study, four typical secondary aluminum smelters were selected as demonstration smelters and the composition of the raw material they used was adjusted to investigate the influence on PCDD/F emissions and profiles. In addition to 17 congeners of 2,3,7,8-PCDD/Fs, 64 congeners of non-2,3,7,8-PCDD/Fs were firstly reported. Strong, positive correlations were found between non-2,3,7,8-PCDD/Fs and 2,3,7,8-PCDD/Fs. The concentrations of 2,3,7,8-PCDD/Fs in stack gas and fly ash samples were 120.7-870.4 pg/Nm3 and 13.40-292.9 ng/g, respectively. Those of non-2,3,7,8-PCDD/Fs in the stack gas and fly ash samples were 84.03-1183.7 pg/Nm3 and 7.20-344.7 ng/g, respectively. The raw material composition was a key factor affecting PCDD/F emissions and profiles. An analysis of Gibbs free energies (ΔGf) showed that non-2,3,7,8-PCDD/Fs could be transformed into 2,3,7,8-PCDD/Fs, which would increase the PCDD/F environmental risks. The emission inventories of 2,3,7,8-PCDD/Fs, non-2,3,7,8-PCDD/Fs, and International Toxic Equivalents from Chinese secondary aluminum smelters in 2013 were 8247 g, 7253 g, and 608.6 g, respectively. The results of this study could contribute to potential risk evaluations and effective reduction of non-2,3,7,8-PCDD/Fs.

Pubmed ID: 30316161

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Agilent Technologies (tool)

RRID:SCR_013575

Company provides laboratories worldwide with analytical instruments and supplies, clinical and diagnostic testing services, consumables, applications and expertise in life sciences and applied chemical markets.

View all literature mentions